1 1

Ivosenib 250mg tablet (ivosidenib)

Ivosenib 250mg tablet (ivosidenib)

Brand Name: osenib 250 mg
Origin: Bangladesh
Small Orders: 1 bottle
Tags: Acute myeloid leukemia , AML Treatment , Anticancer Medicine , Bangladesh Medicine , Bile duct cancer , Cancer Treatment , Cholangiocarcinoma , Everest Pharmaceuticals , film-coated tablet , IDH1 Inhibitor , IDH1 Mutated Cancer , Ivosenib 250 mg , Ivosenib Tablet , Ivosidenib , Ivosidenib 250 mg , Leukemia Medicine , Oncology Medicine , Oral Cancer Medicine , Precision Medicine , Prescription Medicine , Targeted Cancer Therapy , Targeted Therapy
Ver todos los detalles
  • Details
  • Description
Packaging Size: 60 film-coated tablets per HDPE container
Strength: 250 mg
Composition: Ivosidenib 250 mg per film-coated tablet
Treatment: Targeted therapy for certain IDH1-mutated acute myeloid leukemia (AML) and IDH1-mutated cholangiocarcinoma (bile duct cancer), depending on the approved indication and treatment regimen
Form: Film-coated tablet
Brand: osenib 250 mg
Quantity Unit: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Ivosenib 250 mg Tablet (Ivosidenib 250 mg) is an oral targeted anticancer medicine and IDH1 inhibitor manufactured by Everest Pharmaceuticals Ltd. It selectively inhibits mutant IDH1 enzymes, helping reduce abnormal cancer-driving metabolites and supporting the differentiation and control of malignant cells. It is used for certain patients with IDH1-mutated acute myeloid leukemia (AML) and previously treated locally advanced or metastatic cholangiocarcinoma (bile duct cancer)

Everyone Deserves Access to Life-saving Treatment Of Cancer. We are a Trusted Cancer Medicine seller delivering certified medications to every corner of the world.